Mainz Biomed N.V (MYNZ) Short term Debt: 2020-2024
Historic Short term Debt for Mainz Biomed N.V (MYNZ) over the last 1 years, with Dec 2024 value amounting to $1.0 million.
- Mainz Biomed N.V's Short term Debt fell 78.99% to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year decrease of 78.99%. This contributed to the annual value of $1.0 million for FY2024, which is 78.99% down from last year.
- Latest data reveals that Mainz Biomed N.V reported Short term Debt of $1.0 million as of Q4 2024, which was down 78.99% from $4.9 million recorded in Q4 2023.
- Over the past 5 years, Mainz Biomed N.V's Short term Debt peaked at $6.9 million during Q3 2023, and registered a low of $24,527 during Q4 2020.
- Over the past 3 years, Mainz Biomed N.V's median Short term Debt value was $4.9 million (recorded in 2023), while the average stood at $3.9 million.
- In the last 5 years, Mainz Biomed N.V's Short term Debt crashed by 97.62% in 2022 and then soared by 14,998.97% in 2023.
- Over the past 5 years, Mainz Biomed N.V's Short term Debt (Quarterly) stood at $24,527 in 2020, then surged by 5,411.29% to $1.4 million in 2021, then tumbled by 97.62% to $32,181 in 2022, then surged by 14,998.97% to $4.9 million in 2023, then tumbled by 78.99% to $1.0 million in 2024.
- Its Short term Debt was $1.0 million in Q4 2024, compared to $4.9 million in Q4 2023 and $6.9 million in Q3 2023.